Home > Insider Trading > Filing (0001104659-20-082184)

Filing Details

Accession Number:: 0001104659-20-082184
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-07-08 19:54:41
Reporting Period:: 2020-07-06

Accepted Time:: 2020-07-08 19:54:41
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1082554	United Therapeutics Corp	UTHR	Pharmaceutical Preparations (2834)	521984749

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1106578	A Martine Rothblatt	C/O United Therapeutics Corporation 1040 Spring Street Silver Spring MD 20910	Chairman & Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2020-07-06	10,000	$63.22	10,140	No	4	M	Direct
Common Stock	Disposition	2020-07-06	4,484	$118.95	5,656	No	4	S	Direct
Common Stock	Disposition	2020-07-06	5,013	$120.06	643	No	4	S	Direct
Common Stock	Disposition	2020-07-06	503	$120.86	140	No	4	S	Direct
Common Stock	Acquisiton	2020-07-07	10,000	$63.22	10,140	No	4	M	Direct
Common Stock	Disposition	2020-07-07	5,716	$118.92	4,424	No	4	S	Direct
Common Stock	Disposition	2020-07-07	4,284	$119.83	140	No	4	S	Direct
Common Stock	Acquisiton	2020-07-08	10,000	$63.22	10,140	No	4	M	Direct
Common Stock	Disposition	2020-07-08	6,524	$117.44	3,616	No	4	S	Direct
Common Stock	Disposition	2020-07-08	1,751	$118.33	1,865	No	4	S	Direct
Common Stock	Disposition	2020-07-08	1,725	$119.23	140	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Options	Disposition	2020-07-06	10,000	$0.00	10,000	$63.22
Common Stock	Stock Options	Disposition	2020-07-07	10,000	$0.00	10,000	$63.22
Common Stock	Stock Options	Disposition	2020-07-08	10,000	$0.00	10,000	$63.22

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
24,834	2010-12-31	2020-12-31	No	4	M	Direct
14,834	2010-12-31	2020-12-31	No	4	M	Direct
4,834	2010-12-31	2020-12-31	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	166	Indirect	By Spouse
Common Stock	663,879	Indirect	By Trusts

Footnotes

This exercise of options and sale of options is pursuant to a prearranged 10b5-1 trading plan. The trading plan contemplates the exercise and sale of up to 364,834 options with an exercise price of $63.22/share, which were granted in December 2010 and are set to expire at the end of 2020. Assuming relevant conditions are met, this tranche of options will be exercised in daily installments of 10,000 shares during May-July, 2020.
This transaction was executed in multiple trades at prices ranging from $118.62 to $119.59. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $119.665 to $120.63. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $120.695 to $121.07. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $118.32 to $119.29. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $119.335 to $120.32. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $116.98 to $117.965. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $117.99 to $118.92. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $119.02 to $119.59. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.